Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)
Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Pain remains the most debilitating symptom for adult patients suffering from complex regional
pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers.
The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of
much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
Phase:
Phase 2
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre